Paradigm Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-850
| Closed | -$39.1K | – | 635 |
|
|
2016
Q3 | $39.1K | Hold |
850
| – | – | 0.01% | 564 |
|
|
2016
Q2 | $42.7K | Hold |
850
| – | – | 0.01% | 594 |
|
|
2016
Q1 | $45.5K | Hold |
850
| – | – | 0.01% | 605 |
|
|
2015
Q4 | $55.8K | Buy |
850
+50
| +6% | +$3.28K | 0.01% | 642 |
|
|
2015
Q3 | $45.2K | Hold |
800
| – | – | 0.01% | 660 |
|
|
2015
Q2 | $47.3K | Buy |
800
+100
| +14% | +$5.91K | 0.01% | 656 |
|
|
2015
Q1 | $43.6K | Sell |
700
-200
| -22% | -$12.5K | ﹤0.01% | 665 |
|
|
2014
Q4 | $51.8K | Hold |
900
| – | – | 0.01% | 659 |
|
|
2014
Q3 | $48.4K | Sell |
900
-1,400
| -61% | -$75.3K | 0.01% | 688 |
|
|
2014
Q2 | $121K | Hold |
2,300
| – | – | 0.02% | 549 |
|
|
2014
Q1 | $122K | Buy |
2,300
+100
| +5% | +$5.28K | 0.02% | 538 |
|
|
2013
Q4 | $88.2K | Hold |
2,200
| – | – | 0.01% | 580 |
|
|
2013
Q3 | $83.1K | Sell |
2,200
-400
| -15% | -$15.1K | 0.01% | 588 |
|
|
2013
Q2 | $102K | Buy |
+2,600
| New | +$102K | 0.02% | 571 |
|